+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-09-02Number of Pages: 214

Veterinary Therapeutics Market (Product Type - Drugs (Anti-invectives’, Anti-inflammatory, Parasiticides), Vaccines (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines), Medicated Feed Additives (Amino Acids, Antibiotics); Animal Type - Companion Animals, Livestock Animals; Route of Administration - Oral, Parenteral, Topical; Distribution Channel - Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

The global veterinary therapeutics market has witnessed growth at a significant rate in the past few years, owing chiefly to the rising awareness about health and well-being of companion as well as livestock animals. The market is driven by factors such as the increase in ownership of companion animals, rapid introduction of new products capable of combating new varieties of diseases in animals, increased affordability of treatments, and rising expenditure on animal health.

Transparency Market Research estimates that the global veterinary therapeutics market will exhibit a healthy 6.7% CAGR over the period between 2016 and 2024. Expanding at this pace, the market, which had a valuation of US$26.9 bn in 2015, is projected to reach US$50.2 bn by 2024.

Veterinary Therapeutics Drugs Emerge as Most Preferred Product Variety

Of the key product segments in the global veterinary therapeutics market, drugs emerged as the leading segment, accounting for a revenue share of 56.2% of the global market in 2015. Of the key varieties of veterinary drugs examined in the report, the segments of anti-infectives and parasiticides collectively accounted for dominant share of the drugs segment in 2015. These segments are also estimated to dominate the market over the forecasting horizon owing to the high demand for preventive measures against various infectious diseases as well as endoparasites and ectoparasites. The demand for anti-inflammatory drugs is also expected to see a significant rise in the near future as the significance of pain management and the use of NSAIDs, especially in animals, has augmented radically.

The segment of veterinary vaccines is expected to exhibit healthy growth in the next few years owing to development of novel approaches such as recombinant vaccines and DNA vaccines. The rising awareness about prevention and well-being of both livestock as well as companion animals is expected to boost the global demand for veterinary vaccines over the next few years.

veterinary-therapeutics-market

North America to Retain Dominance; Latin America Presents Most Promising Growth Opportunities

The global veterinary therapeutics market is well developed and earns a substantial share of its revenues from developed regions such as North America and Europe. However, regions such as Latin America and Asia Pacific also exhibit significant potential for healthy growth of the veterinary therapeutics market. The market for veterinary therapeutics in North America presently dominates the global market.  Factors such as the presence of superior animal health care base, strong economic growth, increasing trend of pet ownership, and higher emphasis on the prevention of diseases by veterinarians and owners are key to North America’s dominance in the global veterinary therapeutics market. The region’s rapidly increasing demand for animal food products is also expected to propel the livestock animals segment. The segment of companion animals in the region is expanding owing to factors such as the rising pet population and introduction of new product by global players.

In Latin America, which is expected to emerge as one of the most promising markets for veterinary therapeutics, the rising capacity of meat production in countries such as Brazil is compelling several global players to increase their presence to exploit the vast growth opportunities that the region has to offer. Latin America is expected to emerge as one of the leading meat exporters in the world over the course of the next few years. Hence, market vendors are investing in the region to manage the potential rise in demand for drugs, vaccines, and medicated feed additives for the future rise in population of livestock animals. Many domestic vendors in the region have increased their focus on the specialization of swine therapeutics. The segment of poultry therapeutics is also expected to be an attractive area for investment in the region over the next few years.

Some of the key vendors operating in the global veterinary therapeutics market are Boehringer Ingelheim Vetmedica, Bayer Animal Health, Inc., Dechra Animal Health, Ceva Sante Animale, Elanco Animal Health, Merck Animal Health, Virbac S.A., Merial Animal Health, Zoetis, Inc., and Vetoquinol S.A.


Chapter 1. Preface 
1.1. Report Scope and Market Segmentation 
1.2. Research Highlights

Chapter 2. Assumptions and Research Methodology 
2.1. Assumptions
2.2. Research Methodology

Chapter 3. Executive Summary
3.1. Global Veterinary Therapeutics: Market Snapshot
3.2. Market Share Analysis by Region, 2015
3.3. Global Veterinary Therapeutics Market : Opportunity Map

Chapter 4. Market Overview
4.1. Product Overview
4.2. Global Veterinary Therapeutics Market : Key Industry Developments
4.3. Global Veterinary Therapeutics Market : Market Indicators

Chapter 5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
       5.2.1. Demand for High Quality Proteins
       5.2.2. Growth in spend on companion animals globally
       5.2.3. Increased medical and surgical capabilities for companion animals
       5.2.4. Greater emphasis on prevention and wellness by veterinarians and owners
       5.2.5. Increase in ownership of companion animals
       5.2.6. Evolution of new products combating emergence of new diseases in animals
       5.2.7. Development of vaccines and other pharma products to cope up with zoonotic disease concerns
5.3. Restraints
       5.3.1. Low R&D returns and aging product portfolio
       5.3.2. Stringent regulatory framework
       5.3.3. Rising concern about the use of antibiotics and growth promoters in food animals
       5.3.4. Prevalence of counterfeit medicines
5.4. Global Veterinary Therapeutics Market : Opportunity Analysis
5.5. Opportunities
       5.5.1. Biologics and specialty care offer potential opportunities for players to invest in
       5.5.2. Growing awareness and affordability of therapeutics for pets and livestock offer significant opportunity to new entrants
5.6. Key Trends
5.7. Global Veterinary Therapeutics Market Size (US$ Mn) Forecast, 2014–2024
5.8. Porter's Analysis
5.9. Veterinary Therapeutics Market Outlook

Chapter 6. Veterinary Therapeutics Market Analysis, by Product Type
6.1. Key Findings
6.2. Introduction
6.3. Global Veterinary Therapeutics Market Value Share Analysis, by Product Type
6.4. Veterinary Therapeutics Market Analysis, by Product Type 
       6.4.1. Drugs 
       6.4.2. Vaccines
       6.4.3. Medicated Feed Additives
6.5. Global Veterinary Drugs Market Analysis, by Drugs Type
       6.5.1. Anti-infective
       6.5.2. Anti-inflammatory
       6.5.3. Parasiticides
       6.5.4. Others
6.6. Global Veterinary Vaccines Market Analysis, by Vaccines Type
       6.6.1. Inactivated Vaccines
       6.6.2. Live Attenuated Vaccines
       6.6.3. Recombinant Vaccines
       6.6.4. Others
6.7. Global Veterinary Medicated Feed Additives Market Analysis, by Medicated Feed Additives Type
       6.7.1. Antibiotics 
       6.7.2. Amino Acids
       6.7.3. Others
6.8. Market Attractiveness Analysis, by Product Type
6.9. Key Trends

Chapter 7. Veterinary Therapeutics Market Analysis, by Animal Type
7.1. Key Findings
7.2. Introduction
7.3. Global Veterinary Therapeutics Market Value Share Analysis, by Animal Type
7.4. Veterinary Therapeutics Market Analysis, by Animal Type
       7.4.1. Companion
       7.4.2. Livestock
7.5. Market Attractiveness Analysis, by Animal Type
7.6. Key Trends

Chapter 8. Veterinary Therapeutics Market Analysis, by Route of Administration
8.1. Key Findings
8.2. Introduction
8.3. Global Veterinary Therapeutics Market Value Share Analysis, by Route of Administration
8.4. Veterinary Therapeutics Market Analysis, by Route of Administration
       8.4.1. Oral
       8.4.2. Parenteral
       8.4.3. Topical
8.5. Market Attractiveness Analysis, by Route of Administration
8.6. Key Trends

Chapter 9. Veterinary Therapeutics Market Analysis, by Distribution Channel
9.1. Key Findings
9.2. Introduction
9.3. Global Veterinary Therapeutics Market Value Share Analysis, by Distribution Channel
9.4. Veterinary Therapeutics Market Analysis, by Distribution Channel
       9.4.1. Veterinary Hospitals
       9.4.2. Veterinary Clinics
       9.4.3. Pharmacies & Drug stores
       9.4.4. Others
9.5. Market Attractiveness Analysis, by Distribution Channel
9.6. Key Trends

Chapter 10. Veterinary Therapeutics Market Analysis, by Region
10.1. Global Veterinary Therapeutics Market Snapshot, by Country
10.2. Global Veterinary Therapeutics Market Value Share Analysis, by Region
10.3. Veterinary Therapeutics Market Forecast, by Region
10.4. Market Attractiveness Analysis, by Region

Chapter 11. North America Veterinary Therapeutics Market Analysis
11.1. Key Findings
11.2. Market Overview
11.3. Market Analysis, by Product
       11.3.1. Market Value Share Analysis, by Product
       11.3.2. Market Size (US$ Mn) Forecast, by Product
                 11.3.2.1. Drugs 
                 11.3.2.2. Vaccines
                 11.3.2.3. Medicated Feed Additives
11.4. Market Analysis, by Animal
       11.4.1. Market Value Share Analysis, by Animal
       11.4.2. Market Size (US$ Mn) Forecast, by Animal
                 11.4.2.1. Companion
                 11.4.2.2. Livestock
11.5. Market Analysis, by Route of Administration
       11.5.1. Market Value Share Analysis, by Route of Administration
       11.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
                 11.5.2.1. Oral
                 11.5.2.2. Parenteral
                 11.5.2.3. Topical
11.6. Market Analysis, by Distribution Channel
       11.6.1. Market Value Share Analysis, by Distribution Channel
       11.6.2. Market Size (US$ Mn) Forecast, by Distribution Channel
                 11.6.2.1. Veterinary Hospitals
                 11.6.2.2. Veterinary Clinics
                 11.6.2.3. Pharmacies & Drug stores
                 11.6.2.4. Others
11.7. Market Analysis, by Country
       11.7.1. Market Value Share Analysis, by Country
       11.7.2. Market Size (US$ Mn) Forecast, by Country, 2016–2024
                 11.7.2.1. U.S.
                 11.7.2.2. Canada
11.8. Market Attractiveness Analysis
       11.8.1. by Product 
       11.8.2. by Animal
       11.8.3. by Route of Administration
       11.8.4. by Distribution Channel
       11.8.5. by Country
11.9. Market Trends

Chapter 12. Europe Veterinary Therapeutics Market Analysis
12.1. Key Findings
12.2. Market Overview
12.3. Market Analysis, by Product
       12.3.1. Market Value Share Analysis, by Product
       12.3.2. Market Size (US$ Mn) Forecast, by Product
                 12.3.2.1. Drugs 
                 12.3.2.2. Vaccines
                 12.3.2.3. Medicated Feed Additives
12.4. Market Analysis, by Animal
       12.4.1. Market Value Share Analysis, by Animal
       12.4.2. Market Size (US$ Mn) Forecast, by Animal
                 12.4.2.1. Companion
                 12.4.2.2. Livestock
12.5. Market Analysis, by Route of Administration
       12.5.1. Market Value Share Analysis, by Route of Administration
       12.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
                 12.5.2.1. Oral
                 12.5.2.2. Parenteral
                 12.5.2.3. Topical
12.6. Market Analysis, by Distribution Channel
       12.6.1. Market Value Share Analysis, by Distribution Channel
       12.6.2. Market Size (US$ Mn) Forecast, by Distribution Channel
                 12.6.2.1. Veterinary Hospitals
                 12.6.2.2. Veterinary Clinics
                 12.6.2.3. Pharmacies & Drug stores
                 12.6.2.4. Others
12.7. Market Analysis, by Country
       12.7.1. Market Value Share Analysis, by Country
       12.7.2. Market Size (US$ Mn) Forecast, by Country, 2016–2024
                 12.7.2.1. U.K.
                 12.7.2.2. Germany
                 12.7.2.3. Italy
                 12.7.2.4. France
                 12.7.2.5. Spain
                 12.7.2.6. Rest of Europe
12.8. Market Attractiveness Analysis
       12.8.1. by Product 
       12.8.2. by Animal
       12.8.3. by Route of Administration
       12.8.4. by Distribution Channel
       12.8.5. by Country
12.9. Market Trends

Chapter 13. Asia Pacific Veterinary Therapeutics Market Analysis
13.1. Key Findings
13.2. Market Overview
13.3. Market Analysis, by Product
       13.3.1. Market Value Share Analysis, by Product
       13.3.2. Market Size (US$ Mn) Forecast, by Product
                 13.3.2.1. Drugs 
                 13.3.2.2. Vaccines
                 13.3.2.3. Medicated Feed Additives
13.4. Market Analysis, by Animal
       13.4.1. Market Value Share Analysis, by Animal
       13.4.2. Market Size (US$ Mn) Forecast, by Animal
                 13.4.2.1. Companion
                 13.4.2.2. Livestock
13.5. Market Analysis, by Route of Administration
       13.5.1. Market Value Share Analysis, by Route of Administration
       13.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
                 13.5.2.1. Oral
                 13.5.2.2. Parenteral
                 13.5.2.3. Topical
13.6. Market Analysis, by Distribution Channel
       13.6.1. Market Value Share Analysis, by Distribution Channel
       13.6.2. Market Size (US$ Mn) Forecast, by Distribution Channel
                 13.6.2.1. Veterinary Hospitals
                 13.6.2.2. Veterinary Clinics
                 13.6.2.3. Pharmacies & Drug stores
                 13.6.2.4. Others
13.7. Market Analysis, by Country
       13.7.1. Market Value Share Analysis, by Country
       13.7.2. Market Size (US$ Mn) Forecast, by Country, 2016–2024
                 13.7.2.1. China
                 13.7.2.2. Japan
                 13.7.2.3. India
                 13.7.2.4. ANZ
                 13.7.2.5. Rest of APAC
13.8. Market Attractiveness Analysis
       13.8.1. by Product 
       13.8.2. by Animal
       13.8.3. by Route of Administration
       13.8.4. by Distribution Channel
       13.8.5. by Country
13.9. Market Trends

Chapter 14. Latin America Veterinary Therapeutics Market Analysis
14.1. Key Findings
14.2. Market Overview
14.3. Market Analysis, by Product
       14.3.1. Market Value Share Analysis, by Product
       14.3.2. Market Size (US$ Mn) Forecast, by Product
                 14.3.2.1. Drugs 
                 14.3.2.2. Vaccines
                 14.3.2.3. Medicated Feed Additives
14.4. Market Analysis, by Animal
       14.4.1. Market Value Share Analysis, by Animal
       14.4.2. Market Size (US$ Mn) Forecast, by Animal
                 14.4.2.1. Companion
                 14.4.2.2. Livestock
14.5. Market Analysis, by Route of Administration
       14.5.1. Market Value Share Analysis, by Route of Administration
       14.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
                 14.5.2.1. Oral
                 14.5.2.2. Parenteral
                 14.5.2.3. Topical
14.6. Market Analysis, by Distribution Channel
       14.6.1. Market Value Share Analysis, by Distribution Channel
       14.6.2. Market Size (US$ Mn) Forecast, by Distribution Channel
                 14.6.2.1. Veterinary Hospitals
                 14.6.2.2. Veterinary Clinics
                 14.6.2.3. Pharmacies & Drug stores
                 14.6.2.4. Others
14.7. Market Analysis, by Country
       14.7.1. Market Value Share Analysis, by Country
       14.7.2. Market Size (US$ Mn) Forecast, by Country, 2016–2024
                 14.7.2.1. Brazil
                 14.7.2.2. Mexico
                 14.7.2.3. Rest of LATAM
14.8. Market Attractiveness Analysis
       14.8.1. by Product 
       14.8.2. by Animal
       14.8.3. by Route of Administration
       14.8.4. by Distribution Channel
       14.8.5. by Country
14.9. Market Trends

Chapter 15. Middle East & Africa Veterinary Therapeutics Market Analysis
15.1. Key Findings
15.2. Market Overview
15.3. Market Analysis, by Product
       15.3.1. Market Value Share Analysis, by Product
       15.3.2. Market Size (US$ Mn) Forecast, by Product
                 15.3.2.1. Drugs 
                 15.3.2.2. Vaccines
                 15.3.2.3. Medicated Feed Additives
15.4. Market Analysis, by Animal
       15.4.1. Market Value Share Analysis, by Animal
       15.4.2. Market Size (US$ Mn) Forecast, by Animal
                   15.4.2.1. Companion
                   15.4.2.2. Livestock
15.5. Market Analysis, by Route of Administration
       15.5.1. Market Value Share Analysis, by Route of Administration
       15.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
                 15.5.2.1. Oral
                 15.5.2.2. Parenteral
                 15.5.2.3. Topical
15.6. Market Analysis, by Distribution Channel
       15.6.1. Market Value Share Analysis, by Distribution Channel
       15.6.2. Market Size (US$ Mn) Forecast, by Distribution Channel
                 15.6.2.1. Veterinary Hospitals
                 15.6.2.2. Veterinary Clinics
                 15.6.2.3. Pharmacies & Drug stores
                 15.6.2.4. Others
15.7. Market Analysis, by Country
       15.7.1. Market Value Share Analysis, by Country
       15.7.2. Market Size (US$ Mn) Forecast, by Country, 2016–2024
                 15.7.2.1. South Africa
                 15.7.2.2. Saudi Arabia
                 15.7.2.3. UAE
                 15.7.2.4. Rest of MEA
15.8. Market Attractiveness Analysis
       15.8.1. by Product 
       15.8.2. by Animal
       15.8.3. by Route of Administration
       15.8.4. by Distribution Channel
       15.8.5. by Country
15.9. Market Trends

Chapter 16. Company Profiles
16.1. Veterinary Therapeutics Market Share Analysis, by Company (2015)
16.2. Competition Matrix
16.3. Company Profiles
       16.3.1. Bayer AG
                 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                 16.3.1.2. Financial Overview
                 16.3.1.3. Product Portfolio
                 16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
       16.3.2. Boehringer Ingelheim GmbH
                 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                 16.3.2.2. Financial Overview
                 16.3.2.3. Product Portfolio
                 16.3.2.4. SWOT Analysis
                 16.3.2.5. Strategic Overview
       16.3.3. Ceva Santé Animale 
                 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                 16.3.3.2. Financial Overview
                 16.3.3.3. Product Portfolio
                 16.3.3.4. SWOT Analysis
                 16.3.3.5. Strategic Overview
       16.3.4. Dechra Pharmaceuticals PLC
                 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                 16.3.4.2. Financial Overview
                 16.3.4.3. Product Portfolio
                 16.3.4.4. SWOT Analysis
                 16.3.4.5. Strategic Overview
       16.3.5. Eli Lilly and Company (Elanco Animal Health)
                 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                 16.3.5.2. Financial Overview
                 16.3.5.3. Product Portfolio
                 16.3.5.4. SWOT Analysis
                 16.3.5.5. Strategic Overview
       16.3.6. Merck Animal Health 
                 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                 16.3.6.2. Financial Overview
                 16.3.6.3. Product Portfolio
                 16.3.6.4. SWOT Analysis
                 16.3.6.5. Strategic Overview
       16.3.7. Sanofi (Merial Animal Health)
                 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                 16.3.7.2. Financial Overview
                 16.3.7.3. Product Portfolio
                 16.3.7.4. SWOT Analysis
                 16.3.7.5. Strategic Overview
       16.3.8. Virbac
                 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                 16.3.8.2. Financial Overview
                 16.3.8.3. Product Portfolio
                 16.3.8.4. SWOT Analysis
                 16.3.8.5. Strategic Overview
       16.3.9. Vetoquinol S.A.
                 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                 16.3.9.2. Financial Overview
                 16.3.9.3. Product Portfolio
                 16.3.9.4. SWOT Analysis
                 16.3.9.5. Strategic Overview
       16.3.10. Zoetis, Inc. 
                 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                 16.3.10.2. Financial Overview
                 16.3.10.3. Product Portfolio
                 16.3.10.4. SWOT Analysis
                 16.3.10.5. Strategic Overview

List of Figures

Figure 01: Global Veterinary Therapeutics Market Size (US$ Mn) Forecast, 2014–2024
Figure 02: Global Veterinary Therapeutics Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 03: Global Drugs Market Revenue, US$ Mn, 
Figure 04: Global Vaccines Market Revenue, US$ Mn,
Figure 05: Global Fee Additives Market Revenue, US$ Mn, 2014–2024
Figure 06: Global Veterinary Drugs Market Revenue,
Figure 07: Global Veterinary Vaccines Market Revenue,
Figure 08: Global Veterinary Medicated Feed Additives Market Revenue, US$ Mn, 2014–2024
Figure 09: Veterinary Therapeutics Market Attractiveness Analysis, by Product Type
Figure 10: Global Veterinary Therapeutics Market Value Share Analysis, by Animal, 2016 and 2024
Figure 11: Global Companion Animals Market Revenue (US$ Mn), 2014–2024
Figure 12: Global Livestock Animals Market Revenue 
Figure 13: Veterinary Therapeutics Market Attractiveness Analysis, by Animal
Figure 14: Global Veterinary Therapeutics Market Value Share Analysis, by Route of Administration, 2016 and 2024
Figure 15: Global Oral Market Revenue, US$ Mn, 2014–2024
Figure 16: Global Parenteral Market Revenue, US$ Mn, 2014–2024
Figure 17: Global Topical Market Revenue, US$ Mn, 2014–2024
Figure 18: Veterinary Therapeutics Market Attractiveness Analysis, by Route of Administration, 2016
Figure 19: Global Veterinary Therapeutics Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 20: Global Veterinary Hospitals Market Revenue (US$ Mn), 2014–2024
Figure 21: Global Veterinary Clinics Market Revenue (US$ Mn), 2014–2024
Figure 22: Global Pharmacies & Drug Stores Market Revenue (US$ Mn), 2014–2024
Figure 23: Global Other Distribution Channels Market Revenue (US$ Mn), 2014–2024
Figure 24: Veterinary Therapeutics Market Attractiveness Analysis, by Distribution Channel
Figure 25: Global Veterinary Therapeutics Market Value Share Analysis, by Region, 2016 and 2024
Figure 26: Veterinary Therapeutics Market Attractiveness Analysis, by Region
Figure 27: North America Veterinary Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
Figure 28: North America Market Attractiveness Analysis, by Country
Figure 29: North America Market Value Share Analysis, by Product, 2016 and 2024
Figure 30: North America Market Value Share Analysis, by Animal, 2016 and 2024
Figure 31: North America Market Value Share Analysis, by Route of Administration, 2016 and 2024
Figure 32: North America Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 33: North America Market Value Share Analysis, by Country, 2016 and 2024
Figure 34: North America Market Attractiveness Analysis, by Product 
Figure 35: North America Market Attractiveness Analysis, by Animal
Figure 36: North America Market Attractiveness Analysis, by Route of Administration
Figure 37: North America Market Attractiveness Analysis, by Distribution Channel
Figure 38: Europe Veterinary Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
Figure 39: Europe Market Attractiveness Analysis, by Country
Figure 40: Europe Market Value Share Analysis, by Product, 2016 and 2024
Figure 41: Europe Market Value Share Analysis, by Animal, 2016 and 2024
Figure 42: Europe Market Value Share Analysis, by Route of Administration, 2016 and 2024
Figure 43: Europe Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 44: Europe Market Value Share Analysis, by Country, 2016 and 2024
Figure 45: Europe Market Attractiveness Analysis, by Product
Figure 46: Europe Market Attractiveness Analysis, by Animal
Figure 47: Europe Market Attractiveness Analysis, by Route of Administration
Figure 48: Europe Market Attractiveness Analysis, by Distribution Channel
Figure 49: Asia Pacific Veterinary Therapeutics Market Size (US$ Mn) Forecast, 2014–2024
Figure 50: Asia Pacific Market Attractiveness Analysis, by Country
Figure 51: Asia Pacific Market Value Share Analysis, by Product, 2016 and 2024
Figure 52: Asia Pacific Market Value Share Analysis, by Animal, 2016 and 2024
Figure 53: Asia Pacific Market Value Share Analysis, by Route of Administration, 2016 and 2024
Figure 54: Asia Pacific Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 55: Asia Pacific Market Value Share Analysis, by Country, 2016 and 2024
Figure 56: Asia Pacific Market Attractiveness Analysis, by Product
Figure 57: Asia Pacific Market Attractiveness Analysis, by Animal
Figure 58: Asia Pacific Market Attractiveness Analysis, by Route of Administration
Figure 59: Asia Pacific Market Attractiveness Analysis, by Distribution Channel
Figure 60: Latin America Veterinary Therapeutics Market Size (US$ Mn) Forecast, 2014–2024
Figure 61: Latin America Market Attractiveness Analysis, by Country
Figure 62: Latin America Market Value Share Analysis, by Product, 2016 and 2024
Figure 63: Latin America Market Value Share Analysis, by Animal, 2016 and 2024
Figure 64: Latin America Market Value Share Analysis, by Route of Administration, 2016 and 2024
Figure 65: Latin America Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 66: Latin America Market Value Share Analysis, by Country, 2016 and 2024
Figure 67: Latin America Market Attractiveness Analysis, by Product
Figure 68: Latin America Market Attractiveness Analysis, by Animal
Figure 69: Latin America Market Attractiveness Analysis, by Route of Administration
Figure 70: Latin America Market Attractiveness Analysis, by Distribution Channel
Figure 71: Middle East & Africa Veterinary Therapeutics Market Size (US$ Mn) Forecast, 2014–2024
Figure 72: Middle East & Africa Market Attractiveness Analysis, by Country
Figure 73: Middle East & Africa Market Value Share Analysis, by Product, 2016 and 2024
Figure 74: Middle East & Africa Market Value Share Analysis, by Animal, 2016 and 2024
Figure 75: Middle East & Africa Market Value Share Analysis, by Route of Administration, 2016 and 2024
Figure 76: Middle East & Africa Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 77: Middle East & Africa Market Value Share Analysis, by Country, 2016 and 2024
Figure 78: Middle East & Africa Market Attractiveness Analysis, by Product
Figure 79: Middle East & Africa Market Attractiveness Analysis, by Animal
Figure 80: Middle East & Africa Market Attractiveness Analysis, by Route of Administration
Figure 81: Middle East & Africa Market Attractiveness Analysis, by Distribution Channel
Figure 82: Global Veterinary Therapeutics Market Share Analysis, by Company (2015)

List of Tables

Table 01: Global Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2016–2024
Table 02: Global Veterinary Drugs Market Size (US$ Mn) Forecast, 2014–2024
Table 03: Global Veterinary Vaccines Market Size (US$ Mn) Forecast, 2014–2024
Table 04: Global Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Product Type- Medicated Feed Additives, 2015–2024
Table 05: Global Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Animal, 2015–2024
Table 06: Global Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2024
Table 07: Global Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2024
Table 08: Global Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Region, 2016–2024
Table 09: North America Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Product, 2016–2024
Table 10: North America Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Animal, 2016–2024
Table 11: North America Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2024
Table 12: North America Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2024
Table 13: North America Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 14: Europe Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Product, 2016–2024
Table 15: Europe Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Animal, 2016–2024
Table 16: Europe Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2024
Table 17: Europe Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2024
Table 18: Europe Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 19: Asia Pacific Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Product, 2016–2024
Table 20: Asia Pacific Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Animal, 2016–2024
Table 21: Asia Pacific Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2024
Table 22: Asia Pacific Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2024
Table 23: Asia Pacific Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 24: Latin America Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Product, 2014–2024
Table 25: Latin America Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Animal, 2014–2024
Table 26: Latin America Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Route of Administration, 2014–2024
Table 27: Latin America Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 28: Latin America Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 29: Middle East & Africa Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 30: Middle East & Africa Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Animal, 2014–2024
Table 31: Middle East & Africa Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Route of Administration, 2014–2024
Table 32: Middle East & Africa Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 33: Middle East & Africa Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Country, 2014–2024

This report on the global veterinary therapeutics market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global veterinary therapeutics market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global veterinary therapeutics market.

Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market size estimations involved in-depth study of services and product features of different types of services. Additionally, market related factors such as increasing preference for technologically advanced services, product innovation, and growing number of acute and chronic animal and zoonotic diseases in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.

Based on product type, the global veterinary therapeutics market has been segmented into drugs (anti-infectives, anti-inflammatory, parasiticides, and others), vaccines (inactivated vaccines, live attenuated vaccines, recombinant vaccines, and others), and feed additives (amino acids, antibiotics, and others). The market has been further studied from the point of view of major animal types. Based on animal type, the market has been categorized into companion animals and livestock animals. On the basis of route of administration, the market has been segmented into oral, parenteral, and topical. Based on distribution channel, the market has been segmented into veterinary hospitals, veterinary clinics, pharmacies & drug stores, and others.

Geographically, the global veterinary therapeutics market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Japan, India, Australia, South Africa, Brazil, and Mexico. The report also profiles major players in the veterinary therapeutics market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Bayer Animal Health, Boehringer Ingelheim Vetmedica, Inc., Ceva Sante Animale, Dechra Animal Health, Elanco Animal Health, Merck Animal Health, Merial Animal Health, Vetoquinol S.A., Virbac S.A., and Zoetis, Inc.

The global veterinary therapeutics market has been segmented as follows:

Global Veterinary Therapeutics Market, by Product Type

  • Drugs
    • Anti-infectives
    • Anti-inflammatory
    • Parasiticides
    • Others
  • Vaccines
    • Inactivated Vaccines
    • Live Attenuated Vaccines
    • Recombinant Vaccines
    • Others
  • Medicated Feed Additives
    • Amino Acids
    • Antibiotics
    • Others

Global Veterinary Therapeutics Market, by Animal Type

  • Companion Animals
  • Livestock Animals

Global Veterinary Therapeutics Market, by Route of Administration

  • Oral
  • Parenteral
  • Topical

Global Veterinary Therapeutics Market, by Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others

Global Veterinary Therapeutics Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa


 
 
Back To Top